This is part 1 on our conversation on optimizing clinical site selection and evaluation. In this episode Linda Peterson and Julie Sheidy provide some background on the process of site selection from both the sponsors or clinical research organizations (CROs) perspective and the site’s perspective. Key takeaways include:
3:30 – What is the site selection process and what are sponsors looking for?
5:50 – How do you put together a site feasibility questionnaire and where do sponsors begin the selection process?
9:30 – What are the most rate-limiting steps of site selection?
14:30 – What happens if a site does not have the facilities or expertise you need to complete the study? Is it the sponsor’s responsibility or the site’s responsibility to secure that functionality or expertise?
16:25 – Recommendations for what to look for in a clinical site. How do sites evaluate studies they are bringing in?
19:00 – Why it is important to evaluate the community around the site during site selection and do sites search for studies?
20:00 – How do sites facilitate site selection and qualification?
22:00 – A protocol-based workload estimation tool.
24:30 – How do sponsors evaluate how busy sites are? Is it realistic for sponsors to try to evaluate sites workloads during site selection?
28:10 – Julie provides recommendations on how the sponsor or CRO can help with site selection from the site’s perspective.
32:30 – Tips for staying organized and productive during site selection, evaluation, and study startup.
35:00 – How can the sponsor motivate sites to move things forward?
Abbreviations:
CRO = Clinical Research Organization
IRB = Institutional Review Board
CRC = Clinical Research Coordinator
CRA = Clinical Research Associate
On this episode of Chasing Compliance, host Jamie Hijmans and Sr. Manager Sarra De Velance discuss systematic literature search and screening. They discuss the...
This episode is Part 2 of a two-part episode on Abbreviated New Drug Applications (ANDAs). We continue our conversation with our ANDA expert Sandra...
Chasing Compliance: The Global Regulatory Podcast kicks off season two with a two-part episode on abbreviated new drugs applications (ANDAs). Our guest today, Sandra...